Regencell Bioscience Holdings Limited

NasdaqCM:RGC

Location

Market Cap

USD 6.21 B

Share Price

USD 12.56

Avg Daily Volume

1,414,237

Change (1 day)

1.86%

Change (1 year)

57.99%

Change (YTD)

154.25%

Regencell Bioscience Holdings Limited EBIT Margin for the Trailing 12 Months (TTM) ending August 23, 2025: N/A

Regencell Bioscience Holdings Limited EBIT Margin is NA for the Trailing 12 Months (TTM) ending August 23, 2025. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin